BLRX 241220 1.00C (BLRX241220C1000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BLRX241220C1000

Watchlist

0.05
0.000.00%

15min DelayClose Nov 27 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

JonesTrading Maintains BioLine Rx(BLRX.US) With Buy Rating, Maintains Target Price $2
Moomoo NewsNov 26 13:31 ET · Ratings
JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)
TipRanksNov 26 12:45 ET · Ratings
Express News | HC Wainwright & Co. Maintains Buy on BioLine Rx, Lowers Price Target to $9
BenzingaNov 25 12:13 ET
BioLine Rx Analyst Ratings
BenzingaNov 25 12:07 ET · Ratings
BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript
Earnings Call TranscriptsNov 25 10:58 ET
Express News | BioLine RX Ltd: To Evaluate Additional Asset Opportunities in 2025
ReutersNov 25 07:02 ET

Comments

Noobtrader11

Nov 26 02:01

$BioLine Rx (BLRX.US)$ good time to buy? what's the future for the stock?

151625106

Nov 25 20:41

$ZenaTech (ZENA.US)$
BLRX

151625106

Nov 25 20:41

$BioLine Rx (BLRX.US)$

Trytosaveabit

Nov 21 05:35

Hehehe! Here’s the rest!

$BioLine Rx (BLRX.US)$ BioLineRx And Ayrmid Entered Into A License Agreement For Motixafortide (Commercially Sold In The US As Aphexda), BioLineRx Will Receive A $10M Upfront Payment And Is Also Eligible To Receive Up To An Additional $87M Of Potential Commercial Milestones, Plus Royalties Between 18%-23% On Net Sales Of Aphexda
Aphexda is Biolinerx's FDA-Approved Stem Cell Mobilization Agent Indicated In Combination With Filgrastim For Collection And Subsequent Autologous...

Trytosaveabit

Nov 21 05:32

Hmm! News

$BioLine Rx (BLRX.US)$ Reuters· 1 min ago
BioLine RX Ltd - Biolinerx to Receive $10 Mln Upfront, up to $87 Mln in Milestones